Title : Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours.

Pub. Date : 2022 Apr

PMID : 34887522






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We performed in vivo preclinical studies of the HSP90 inhibitor onalespib with olaparib and conducted a Phase 1 combination study. olaparib heat shock protein 90 alpha family class A member 1 Homo sapiens